Maze Therapeutics stock rating held at Buy by TD Cowen on trial data
Corroborated by 1 source from 1 publisher
globalcrime7h ago
TL;DR
Maze Therapeutics stock rating held at Buy by TD Cowen on trial data.
Sources
1
Investing.com News
https://www.investing.com/news/earnings/maze-therapeutics-stock-soars-22-on-positive-trial-data-for-mze829-93CH-4579653
12h ago
2
Investing.com News
https://www.investing.com/news/analyst-ratings/maze-therapeutics-stock-rating-held-at-buy-by-td-cowen-on-trial-data-93CH-4580557
7h ago
3
Investing.com News
https://www.investing.com/news/analyst-ratings/btig-reiterates-maze-therapeutics-stock-rating-on-trial-results-93CH-4580560
7h ago